Skip to main content
Clinical Trials/ISRCTN87039596
ISRCTN87039596
Completed
Not Applicable

A randomised controlled trial to evaluate whether zoledronate prevents bone loss in acute multiple sclerosis

orth Bristol NHS Trust (UK)0 sites40 target enrollmentMay 5, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple sclerosis
Sponsor
orth Bristol NHS Trust (UK)
Enrollment
40
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 5, 2009
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orth Bristol NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 \- 65 years (either sex) with a diagnosis of multiple sclerosis (MS)
  • 2\. Acute flare up requiring treatment with a corticosteroid
  • 3\. Able to attend for study investigations and assessments
  • 4\. Willing and able to provide informed consent

Exclusion Criteria

  • 1\. Previous diagnosis of osteoporosis
  • 2\. Bone therapy within previous 12 months
  • 3\. Previous bisphosphonate therapy at any time
  • 4\. Associated disorder that may affect bone metabolism
  • 5\. Pregnancy
  • 6\. Breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials